Evidence map›Paper›PMID 38913614›Full record

ArticlePloS one2024

Relative contribution of biomedical, demographic, and socioeconomic factors to COVID-19 vaccine receipt in rural India.

Bethany F Ferris, Suganthi Balasubramanian, Anuradha Rajamanickam, Saravanan Munisankar, Bindu Dasan, Pradeep A Menon, P'ng Loke, Subash Babu, Goylette F Chami

Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04813328 (A Pilot Study of the Effects of Helminth Infection and SARS-CoV-2 Seropositivity on Immune Response and the Intestinal Microbiota in India), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04813328 active not recruitingnot on this map

A Pilot Study of the Effects of Helminth Infection and SARS-CoV-2 Seropositivity on Immune Response and the Intestinal Microbiota in India

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2021 to 2026Enrolled1,500ConditionsCOVID-19
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bethany F FerrisNuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Suganthi BalasubramanianNational Institutes of Health - National Institute for Research in Tuberculosis -International Center for Excellence in Research (NIH-ICER), Chennai, Tamil Nadu, India.ORCID 0000-0002-0861-7975
Anuradha RajamanickamNational Institutes of Health - National Institute for Research in Tuberculosis -International Center for Excellence in Research (NIH-ICER), Chennai, Tamil Nadu, India.
Saravanan MunisankarNational Institutes of Health - National Institute for Research in Tuberculosis -International Center for Excellence in Research (NIH-ICER), Chennai, Tamil Nadu, India.
Bindu DasanNational Institutes of Health - National Institute for Research in Tuberculosis -International Center for Excellence in Research (NIH-ICER), Chennai, Tamil Nadu, India.
Pradeep A MenonIndian Council of Medical Research - National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
P'ng LokeLaboratory of Parasitic Diseases, National Institutes of Health National Institutes of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States of America.
Subash BabuNational Institutes of Health - National Institute for Research in Tuberculosis -International Center for Excellence in Research (NIH-ICER), Chennai, Tamil Nadu, India.
Goylette F ChamiNuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, Oxfordshire, United Kingdom.ORCID 0000-0002-4653-0846

Funding

India International Center for Excellence in ResearchZIAAI001065 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2025
$19.0M
6 · The paper itself

Abstract

backgroundIn the first year of roll-out, vaccination for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) prevented almost 20 million deaths from coronavirus disease 2019 (COVID-19). Yet, little is known about the factors influencing access to vaccination at the individual level within rural poor settings of low-income countries. The aim of this study was to examine determinants of vaccine receipt in rural India.

methodsA census of a rural village in Tamil Nadu was undertaken from June 2021 to September 2022. We surveyed 775 participants from 262 households. Household-level data on socioeconomic status (SES), water, sanitation, and hygiene practices, and individual-level demographic information, travel history, and biomedical data, including anthropometry, vital signs, and comorbidities, were collected. Logistic regression models with 5-fold cross-validation were used to identify the biomedical, demographic, and socioeconomic determinants of vaccine receipt and the timing of receipt within the first 30 days of eligibility. Vaccine ineligible participants were excluded leaving 659 eligible participants. There were 650 eligible participants with complete biomedical, demographic, and socioeconomic data.

resultsThere were 68.0% and 34.0% of individuals (N = 650) who had received one and two vaccine doses, respectively. Participants with household ownership of a permanent account number (PAN) or ration card were 2.15 (95% CI:1.32-3.52) or 3.02 (95% CI:1.72-5.29) times more likely to receive at least one vaccine dose compared to households with no ownership of such cards. Participants employed as housewives or self-employed non-agricultural workers were 65% (95% CI:0.19-0.67) or 59% (95% CI:0.22-0.76) less likely to receive at least one vaccine dose compared to salaried workers. Household PAN card ownership, occupation and age were linked to the timing of vaccine receipt. Participants aged ≤18 and 45-60 years were 17.74 (95% CI:5.07-62.03) and 5.51 (95% CI:2.74-11.10) times more likely to receive a vaccine within 30 days of eligibility compared to 19-44-year-olds. Biomedical factors including BMI, vital signs, comorbidities, and COVID-19 specific symptoms were not consistently associated with vaccine receipt or timing of receipt. No support was found that travel history, contact with COVID-19 cases, and hospital admissions influenced vaccine receipt or timing of receipt.

conclusionFactors linked to SES were linked to vaccine receipt, more so than biomedical factors which were targeted by vaccine policies. Future research should explore if government interventions including vaccine mandates, barriers to vaccine access, or peer influence linked to workplace or targeted vaccine promotion campaigns underpin these findings.

Indexed as

COVID-19COVID-19 VaccinesRural PopulationSocioeconomic FactorsAdolescentAdultFemaleHumansIndiaMaleMiddle AgedSARS-CoV-2VaccinationYoung AdultCOVID-19 Vaccines

Identifiers

PMID38913614
PMCPMC11195973

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.